Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-06 6:55 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
5,000 | $115.03 | $575,149 | 59,080 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-26 8:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
2,104 | $116.37 | $244,850 | 20,647 (Direct) |
View |
| 2024-09-20 Sale |
2024-09-24 7:41 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,275 | $103.94 | $132,518 | 24,610 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 7:59 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
13,293 | $86.26 | $1,146,704 | 65,530 (Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 6:50 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $88.46 | $12,384 | 71,225 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-10 4:30 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,696 | $75.64 | $128,283 | 8,857 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 6:55 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
40,201 | $0 | 59,080 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:38 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
12,819 | $0 | 23,879 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:38 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
9,587 | $120 | 23,879 (Direct) |
View |
| 2024-12-05 Tax Withholding |
2024-12-06 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,859 | $123.51 | 22,751 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,486 | $0 | 33,591 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,417 | $80.72 | 33,591 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-19 5:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
69 | $57.22 | 33,591 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
753 | $0 | 31,708 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
207 | $57.22 | 31,708 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 9:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
546 | $70.04 | 31,708 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
267 | $60.71 | 23,913 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,917 | $0 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,544 | $63.62 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
145 | $68.74 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
5,022 | $52.84 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
206 | $57.22 | 65,530 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A 2030-02-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,264 | $0 | 71,225 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
36,480 | $0 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
325 | $58.49 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $57.22 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
799 | $55.75 | 71,225 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,479 | $74.65 | 21,423 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,269 | $59.61 | 22,902 (Direct) |
View |
| 2023-10-01 Tax Withholding |
2023-10-03 4:36 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
346 | $59.92 | 24,171 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
375 | $56.78 | 24,892 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:54 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
22,465 | $0 | 40,561 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
849 | $72.98 | 18,096 (Direct) |
View |
| 2022-12-30 Other |
2023-01-04 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
275 | $56.78 | 19,220 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,620 | $0 | 6,620 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:13 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
31,000 | $0 | 38,670 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,187 | $72.9 | 7,670 (Direct) |
View |
Ownership |
2022-11-07 8:26 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
0 | $0 | 62,802 (Direct) |
View |